Angiotech fleshes out orthopaedic business
This article was originally published in Clinica
In a drive to further establish itself in the bone and spinal surgery arena, Angiotech Pharmaceuticals has sealed milestone deals with two orthopaedics companies, Orthovita and NeuColl.
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.